Advances in deconvoluting complex disease processes, enabling genomic, proteomic,
metabolomic and imaging technologies, highthroughput drug discovery and development …

The refinement of disease taxonomy utilizing molecular phenotypes has led to significant
improvements in the precision of disease diagnosis and customization of treatment options …

Individualized patient management is rapidly expanding, fueled by unprecedented
innovation that spans modern medical discovery, development and delivery [1, 2]. This next …

Disease biomarkers are defined to diagnose various phases of diseases, monitor severities
of diseases and responses to therapies, or predict prognosis of patients. Disease-specific …

Advances in decoding integrated biological processes; the surge in enabling technologies
including the highthroughput platforms of genomics, proteomics, and metabolomics; and the …

Biomarkers are the pillars of precision medicine and are delivering on expectations of
molecular, quantitative health. These features have made clinical decisions more precise …

Today, the practice of medicine remains largely empirical. Physicians generally rely on
matching patterns in patient history, symptoms, and laboratory data to make the diagnosis …

Patients expect medical treatments that work and are safe and “right” for them as individuals.
Biomarkers can help bio-pharmaceutical and diagnostics companies to focus more on …

Translational medicine, the exchange between laboratory (bench) and the clinic (bedside),
is decidedly taking on a vital role. Many companies are now focusing on a translational …

drugs? This focus on drug action and disposition provided the fundamental algorithms of
personalized medicine in which the right drug is used in the right patient at the right dose (for …